Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (91-100 of 194) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|April 18, 2002
On the eve of protein destruction: ubiquitin research begins to pay offKen Garber
Journal of the National Cancer Institute|February 14, 2015
Oncologists push beyond new lung cancer genomic testing guidelinesKen Garber
Nature Reviews. Drug Discovery|July 2, 2015
A β-lactamase inhibitor revival provides new hope for old antibioticsKen Garber
Nature Biotechnology|November 17, 2022
The lysosomal degradersKen Garber
Nature Reviews. Drug Discovery|March 24, 2026
Can a first disease-modifying osteoarthritis drug make it past the FDA?Ken Garber
Nature Reviews. Drug Discovery|January 8, 2020
Immune agonist antibodies face critical testKen Garber
Nature Biotechnology|August 11, 2010
Industry makes strides in melanomaKen Garber
Journal of the National Cancer Institute|November 10, 2010
Of Ephs and ephrins: companies target guidance molecules in cancerKen Garber
Journal of the National Cancer Institute|February 10, 2011
Beyond sequencing: new diagnostic tests turn to pathwaysKen Garber
Nature Biotechnology|June 10, 2016
Bristol-Myers Squibb locks into novel autoimmune strategyKen Garber
Pageof 20

Showing results (91-100 of 194) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|April 18, 2002
On the eve of protein destruction: ubiquitin research begins to pay offKen Garber
Journal of the National Cancer Institute|February 14, 2015
Oncologists push beyond new lung cancer genomic testing guidelinesKen Garber
Nature Reviews. Drug Discovery|July 2, 2015
A β-lactamase inhibitor revival provides new hope for old antibioticsKen Garber
Nature Biotechnology|November 17, 2022
The lysosomal degradersKen Garber
Nature Reviews. Drug Discovery|March 24, 2026
Can a first disease-modifying osteoarthritis drug make it past the FDA?Ken Garber
Nature Reviews. Drug Discovery|January 8, 2020
Immune agonist antibodies face critical testKen Garber
Nature Biotechnology|August 11, 2010
Industry makes strides in melanomaKen Garber
Journal of the National Cancer Institute|November 10, 2010
Of Ephs and ephrins: companies target guidance molecules in cancerKen Garber
Journal of the National Cancer Institute|February 10, 2011
Beyond sequencing: new diagnostic tests turn to pathwaysKen Garber
Nature Biotechnology|June 10, 2016
Bristol-Myers Squibb locks into novel autoimmune strategyKen Garber
Pageof 20